Hepatitis E virus inhibits Type I interferon induction by ORF1 products

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 11924-11932

  Nan, Yuchen ^a   Yu, Ying ^a   Ma, Zexu ^a   Khattar, Sunil K ^a   Fredericksen, Brenda ^b,c   Zhang, Yan Jin ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b Bldg 142   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEUBIQUITINASE; GREEN FLUORESCENT PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; MEMBRANE PROTEIN; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN TBK 1; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; PRIMER DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HEK293 CELL LINE; HEPATITIS E VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTERFERON INDUCTION; NONHUMAN; OPEN READING FRAME; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REPLICON; UBIQUITINATION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PHYSIOLOGY; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; HEK293 CELLS; HEPATITIS E VIRUS; HUMANS; INTERFERON TYPE I; OPEN READING FRAMES; PHOSPHORYLATION; UBIQUITINATION; VIRAL PROTEINS;

EID: 84907445220     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01935-14     Document Type: Article

References (54)

1. Khuroo MS. 2011. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 161:3-14. http://dx.doi.org/10.1016/j.virusres.2011.02.007.
2. Kamar N, Dalton HR, Abravanel F, Izopet J. 2014. Hepatitis E virus infection. Clin. Microbiol. Rev. 27:116-138. http://dx.doi.org/10.1128 /CMR.00057-13.
3. Haqshenas G, Shivaprasad HL, Woolcock PR, Read DH, Meng XJ. 2001. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J. Gen. Virol. 82:2449-2462.
4. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, Thacker BJ, Emerson SU. 1997. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U. S. A. 94:9860-9865. http://dx.doi.org/10.1073/pnas.94.18.9860.
5. Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg. Infect. Dis. 11:1958-1960. http://dx.doi.org/10.3201/eid1112.051041.
6. Emerson SU, Purcell RH. 2003. Hepatitis E virus. Rev. Med. Virol. 13: 145-154. http://dx.doi.org/10.1002/rmv.384.
7. Mizuo H, Suzuki K, Takikawa Y, Sugai Y, Tokita H, Akahane Y, Itoh K, Gotanda Y, Takahashi M, Nishizawa T, Okamoto H. 2002. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol. 40:3209-3218. http://dx.doi.org/10.1128/JCM.40.9.3209-3218.2002.
8. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131. http://dx.doi.org/10.1016/0042-6822(91)90760-9.
9. Yu C, Boon D, McDonald SL, Myers TG, Tomioka K, Nguyen H, Engle RE, Govindarajan S, Emerson SU, Purcell RH. 2010. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J. Virol. 84:11264-11278. http://dx.doi.org/10.1128/JVI.01205-10.
10. Graff J, Torian U, Nguyen H, Emerson SU. 2006. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 80:5919-5926. http://dx.doi.org/10.1128/JVI.00046-06.
11. Giles RE, Ruddle FH. 1973. Production of Sendai virus for cell fusion. In vitro 9:103-107. http://dx.doi.org/10.1007/BF02616007.
12. Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. 2004. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J. Virol. 78:4838-4846. http://dx.doi.org/10.1128/JVI.78.9.4838-4846.2004.
13. Wang R, Nan Y, Yu Y, Zhang YJ. 2013. Porcine reproductive and respiratory syndrome virus Nsp1beta inhibits interferon-activated JAK/STAT signal transduction by inducing karyopherin-alpha1 degradation. J. Virol. 87:5219-5228. http://dx.doi.org/10.1128/JVI.02643-12.
14. Wang R, Nan Y, Yu Y, Yang Z, Zhang YJ. 2013. Variable interference with interferon signal transduction by different strains of porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 166:493-503. http://dx.doi.org/10.1016/j.vetmic.2013.07.022.
15. Emerson SU, Zhang M, Meng XJ, Nguyen H, St Claire M, Govindarajan S, Huang YK, Purcell RH. 2001. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cisreactive element. Proc. Natl. Acad. Sci. U. S. A. 98:15270-15275. http://dx.doi.org/10.1073/pnas.251555098.
16. Graff J, Nguyen H, Kasorndorkbua C, Halbur PG, St Claire M, Purcell RH, Emerson SU. 2005. In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis E virus genomes and replicons. J. Virol. 79:1017-1026. http://dx.doi.org/10.1128/JVI.79.2.1017-1026.2005.
17. Gale M, Jr, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945. http://dx.doi.org/10.1038/nature04078.
18. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M, Jr, Akira S, Yonehara S, Kato A, Fujita T. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-2858. http://dx.doi.org/10.4049/jimmunol.175.5.2851.
19. Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M. 2000. NAK is an IkappaB kinase-activating kinase. Nature 404:778-782. http://dx.doi.org/10.1038/35008109.
20. Peters RT, Liao SM, Maniatis T. 2000. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol. Cell 5:513-522. http://dx.doi.org/10.1016/S1097-2765(00)80445-1.
21. Kannan H, Fan S, Patel D, Bossis I, Zhang YJ. 2009. The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J. Virol. 83:6375-6382. http://dx.doi.org/10.1128 /JVI.02571-08.
22. Zhang YJ, Wang KY, Stein DA, Patel D, Watkins R, Moulton HM, Iversen PL, Matson DO. 2007. Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcomaassociated herpesvirus by morpholino oligomers. Antiviral Res. 73:12-23. http://dx.doi.org/10.1016/j.antiviral.2006.05.017.
23. Patel D, Opriessnig T, Stein DA, Halbur PG, Meng XJ, Iversen PL, Zhang YJ. 2008. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication. Antiviral Res. 77:95-107. http://dx.doi.org/10.1016/j.antiviral.2007.09.002.
24. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
25. Nan Y, Wang R, Shen M, Faaberg KS, Samal SK, Zhang YJ. 2012. Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 432:261-270. http://dx.doi.org/10.1016/j.virol.2012.05.015.
26. Patel D, Nan Y, Shen M, Ritthipichai K, Zhu X, Zhang YJ. 2010. Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J. Virol. 84: 11045-11055. http://dx.doi.org/10.1128/JVI.00655-10.
27. Nan Y, Ma Z, Wang R, Yu Y, Kannan H, Fredericksen B, Zhang YJ. 2014. Enhancement of interferon induction by ORF3 product of hepatitis E virus. J. Virol. 88:8696-8705. http://dx.doi.org/10.1128/JVI.01228-14.
28. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, Bendall RP, Keane FE, Purcell RH, Emerson SU. 2011. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc. Natl. Acad. Sci. U. S. A. 108:2438-2443. http://dx.doi.org/10.1073/pnas.1018878108.
29. Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. 1992. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. U. S. A. 89:8259-8263. http://dx.doi.org/10.1073/pnas.89.17.8259.
30. Parvez MK. 2013. Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity. Virus Res. 178:553-556. http://dx.doi.org/10.1016/j.virusres.2013.07.020.
31. Beura LK, Sarkar SN, Kwon B, Subramaniam S, Jones C, Pattnaik AK, Osorio FA. 2010. Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation. J. Virol. 84:1574-1584. http://dx.doi.org/10.1128/JVI.01326-09.
32. Foy E, Li K, Sumpter R, Jr, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U. S. A. 102:2986-2991. http://dx.doi.org/10.1073/pnas.0408707102.
33. Lu LL, Puri M, Horvath CM, Sen GC. 2008. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 283:14269-14276. http://dx.doi.org/10.1074/jbc.M710089200.
34. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
35. Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92: 2088-2092. http://dx.doi.org/10.1099/vir.0.033738-0.
36. Maelfait J, Beyaert R. 2012. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol. Mol. Biol. Rev. 76:33-45. http://dx.doi.org/10.1128/MMBR.05012-11.
37. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8:907-922. http://dx.doi.org/10.1111/j.1462-5822.2006.00716.x.
38. Hartman AL, Bird BH, Towner JS, Antoniadou ZA, Zaki SR, Nichol ST. 2008. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus. J. Virol. 82:2699-2704. http://dx.doi.org/10.1128 /JVI.02344-07.
39. Bauhofer O, Summerfield A, Sakoda Y, Tratschin JD, Hofmann MA, Ruggli N. 2007. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J. Virol. 81: 3087-3096. http://dx.doi.org/10.1128/JVI.02032-06.
40. Gottipati K, Ruggli N, Gerber M, Tratschin JD, Benning M, Bellamy H, Choi KH. 2013. The structure of classical swine fever virus N(pro): a novel cysteine autoprotease and zinc-binding protein involved in subversion of type I interferon induction. PLoS Pathog. 9:e1003704. http://dx.doi.org /10.1371/journal.ppat.1003704.
41. Han W, Li X, Fu X. 2011. The macro domain protein family: structure, functions, and their potential therapeutic implications. Mutat. Res. 727: 86-103. http://dx.doi.org/10.1016/j.mrrev.2011.03.001.
42. Egloff MP, Malet H, Putics A, Heinonen M, Dutartre H, Frangeul A, Gruez A, Campanacci V, Cambillau C, Ziebuhr J, Ahola T, Canard B. 2006. Structural and functional basis for ADP-ribose and poly(ADPribose) binding by viral macro domains. J. Virol. 80:8493-8502. http://dx.doi.org/10.1128/JVI.00713-06.
43. Marr LD, Wang CY, Frey TK. 1994. Expression of the rubella virus nonstructural protein ORF and demonstration of proteolytic processing. Virology 198:586-592. http://dx.doi.org/10.1006/viro.1994.1070.
44. Liu X, Wang Q, Chen W, Wang C. 2013. Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev. 24:559-570. http://dx.doi.org/10.1016/j.cytogfr.2013.07.002.
45. Amerik AY, Hochstrasser M. 2004. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695:189-207. http://dx.doi.org/10.1016/j.bbamcr.2004.10.003.
46. van Kasteren PB, Bailey-Elkin BA, James TW, Ninaber DK, Beugeling C, Khajehpour M, Snijder EJ, Mark BL, Kikkert M. 2013. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. U. S. A. 110:E838-E847. http://dx.doi.org/10.1073/pnas.1218464110.
47. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, Chen Z, Xiao S. 2011. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85:3758-3766. http://dx.doi.org/10.1128 /JVI.02589-10.
48. Herold J, Siddell SG, Gorbalenya AE. 1999. A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold. J. Biol. Chem. 274:14918-14925. http://dx.doi.org/10.1074/jbc.274.21.14918.
49. Parvez MK, Khan AA. 2014. Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease. Virus Res. 179:220-224. http://dx.doi.org/10.1016/j.virusres.2013.11.016.
50. Paliwal D, Panda SK, Kapur N, Varma SP, Durgapal H. 2014. Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. J. Gen. Virol. 95: 1689-1700. http://dx.doi.org/10.1099/vir.0.066142-0.
51. Ratia K, Saikatendu KS, Santarsiero BD, Barretto N, Baker SC, Stevens RC, Mesecar AD. 2006. Severe acute respiratory syndrome coronavirus papainlike protease: structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. U. S. A. 103:5717-5722. http://dx.doi.org/10.1073/pnas.0510851103.
52. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R. 2005. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 79: 15199-15208. http://dx.doi.org/10.1128/JVI.79.24.15199-15208.2005.
53. Ratia K, Pegan S, Takayama J, Sleeman K, Coughlin M, Baliji S, Chaudhuri R, Fu W, Prabhakar BS, Johnson ME, Baker SC, Ghosh AK, Mesecar AD. 2008. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. U. S. A. 105:16119-16124. http://dx.doi.org/10.1073/pnas.0805240105.
54. Jameel S. 1999. Molecular biology and pathogenesis of hepatitis E virus. Expert Rev. Mol. Med. 1999:1-16.